PRESS RELEASE published on 01/31/2025 at 08:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Median Technologies communique ses indicateurs financiers clés 2024 et perspectives 2025, incluant des avancées sur eyonis™ LCS pour le dépistage du cancer du poumon Indicateurs Financiers Median Technologies Cancer Du Poumon Eyonis LCS Perspectives 2025
PRESS RELEASE published on 01/31/2025 at 08:00, 1 year 7 months ago Inside Information / Other news releases Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth
BRIEF published on 01/24/2025 at 08:05, 1 year 7 months ago Median Technologies Secures Up to €47.5 Million for AI Lung Cancer Diagnostics European Investment Bank Median Technologies AI Lung Cancer Diagnostics Eyonis™ EU And US Commercialization
BRIEF published on 01/24/2025 at 08:05, 1 year 7 months ago Median Technologies lève jusqu'à 47,5 millions d'euros pour le diagnostic du cancer du poumon par l'IA Banque Européenne D'investissement Technologies Médianes Eyonis™ Diagnostic Du Cancer Du Poumon Par IA Commercialisation Dans L'UE Et Aux États-Unis
PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 7 months ago Inside Information / Other news releases Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025 AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Median Technologies finalise des financements de 47,5 millions d'euros pour approuver et commercialiser eyonis™ LCS aux États-Unis et en Europe. Nouveaux prêts de la BEI et financement d'IRIS soutiennent le projet Financement IRIS Median Technologies BEI Eyonis LCS
BRIEF published on 11/26/2024 at 17:50, 1 year 9 months ago Median Technologies Showcases AI Lung Cancer Diagnostic at RSNA 2024 Clinical Trials Eyonis™ LCS RSNA 2024 AI-powered Diagnostics Lung Cancer Screening
BRIEF published on 11/26/2024 at 17:50, 1 year 9 months ago Median Technologies présente le diagnostic du cancer du poumon par IA au RSNA 2024 Essais Cliniques Eyonis™ LCS RSNA 2024 Diagnostics Basés Sur L'IA Dépistage Du Cancer Du Poumon
PRESS RELEASE published on 11/26/2024 at 17:45, 1 year 9 months ago Inside Information / Other news releases Median Technologies to showcase AI-powered lung cancer diagnostic eyonis™ LCS at RSNA 2024. Company presents latest developments and REALITY study results to experts in medical imaging conference AI-powered Median Technologies Eyonis LCS RSNA 2024 Lung Cancer Diagnostic
BRIEF published on 10/30/2024 at 17:50, 1 year 10 months ago Median Technologies et l'IA dans le dépistage du cancer du poumon Intelligence Artificielle Cancer Du Poumon Technologies Médicales Dépistage Médical Webconférence 2024
Published on 09/12/2026 at 02:35, 1 day 5 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 8 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 10 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 14 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 14 hours 8 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 9 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 9 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 12 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 12 hours ago Availability of the 2026 Interim Financial Report
